Allogene Therapeutics Inc. (ALLO) Director Arie Belldegrun Purchases 35,000 Shares

Share on StockTwits

Allogene Therapeutics Inc. (NASDAQ:ALLO) Director Arie Belldegrun bought 35,000 shares of the company’s stock in a transaction dated Monday, October 15th. The shares were purchased at an average price of $18.00 per share, with a total value of $630,000.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Allogene Therapeutics stock opened at $23.40 on Friday. Allogene Therapeutics Inc. has a 1-year low of $21.67 and a 1-year high of $27.72.

Read More: Can individual investors take part in an IPO?

Receive News & Ratings for Allogene Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allogene Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Crestline Management LP Has $2.34 Million Stake in Western Digital Corp
Crestline Management LP Has $2.34 Million Stake in Western Digital Corp
Stanley Black & Decker, Inc.  Shares Bought by Lucia Wealth Services LLC
Stanley Black & Decker, Inc. Shares Bought by Lucia Wealth Services LLC
Lucia Wealth Services LLC Takes Position in Goldman Sachs ActiveBeta U.S. Large Cap Equity ETF
Lucia Wealth Services LLC Takes Position in Goldman Sachs ActiveBeta U.S. Large Cap Equity ETF
Dynamic Technology Lab Private Ltd Takes $910,000 Position in Noble Co. PLC
Dynamic Technology Lab Private Ltd Takes $910,000 Position in Noble Co. PLC
Elgethun Capital Management Sells 1,652 Shares of Walmart Inc
Elgethun Capital Management Sells 1,652 Shares of Walmart Inc
First Republic Investment Management Inc. Acquires 3,555 Shares of Alexandria Real Estate Equities Inc
First Republic Investment Management Inc. Acquires 3,555 Shares of Alexandria Real Estate Equities Inc


© 2006-2018 Ticker Report